Copeptin Applying in Forensic Pathological Diagnosis of Sudden Cardiac Death Caused by Acute Myocardial Infarction

WANG Daixin, ZHANG Youyou, ZHANG Shunping, WAN Jia, HUANG Wanqi, ZHOU Xiaowei

Forensic Science and Technology ›› 2019, Vol. 44 ›› Issue (2) : 155-158. DOI: 10.16467/j.1008-3650.2019.02.014
Reviews

Copeptin Applying in Forensic Pathological Diagnosis of Sudden Cardiac Death Caused by Acute Myocardial Infarction

  • WANG Daixin1, ZHANG Youyou2, ZHANG Shunping3, WAN Jia1, HUANG Wanqi1, ZHOU Xiaowei4,*
Author information +
History +

Abstract

Sudden death is a serious syndrome, threating to human life and health, thus having received high attention in clinical practice and forensic identification. As the commonest type of sudden death, sudden cardiac death has long been focused in the forensic pathology identification and research. Acute myocardial ischemia is the most crucial cause of sudden death due to sudden cardiac death. Therefore, how to define the early acute myocardial ischemia is a hotspot in forensic research, also a key pivot in clinical prevention against myocardial infarction. This article reviews about copeptin of its structure, physiological and pathological roles, clinical diagnostic value and forensic applicable prospects, aiming to analyze whether it can be used as an indicator of early myocardial ischemia for sudden cardiac death, and provide reference for further study on pathophysiological mechanism of sudden death.

Key words

copeptin / forensic pathology / sudden cardiac death / acute myocardial infarction

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
WANG Daixin, ZHANG Youyou, ZHANG Shunping, WAN Jia, HUANG Wanqi, ZHOU Xiaowei. Copeptin Applying in Forensic Pathological Diagnosis of Sudden Cardiac Death Caused by Acute Myocardial Infarction. Forensic Science and Technology. 2019, 44(2): 155-158 https://doi.org/10.16467/j.1008-3650.2019.02.014

References

[1] 从斌. 法医病理学[M]. 5版. 北京:人民卫生出版社,2016:381-416.
[2] KEHL D W, IQBAL N, FARD A, et al.Biomarkers in acute myocardial injury[J]. Translational Research, 2012, 159(4):252-264.
[3] KHAN S, DHILLON O, OBRIEN R, et al.C-terminal provasopressin (copeptin) as a novel and prognostic marker in acute myocardial infarction: leicester acute myocardial infarction peptide (LAMP) study[J]. Circulation, 2017,115(16):2103-2110.
[4] 刘晓斌,黄子扬. 生长分化因子15与心血管疾病[J]. 中华高血压杂志,2012(3):228-231.
[5] WOLLERT K C, KEMPF T, PETER T, et al.Prognostic value of growth-differentiation factor 15 in patients with non-ST-segment elevation acute coronary syndrome[J]. Circulation,2007,115(8):962-971.
[6] MORGENTHALER N G, STRUCK J, ALONSO C, et al.Assay for the measurement of copeptin, a stable peptide derived from the precursor of vasopressin[J]. Clinical Chemistry,2006,5:112-119.
[7] BALANESCU S, KOPP P, GASKILL M B, et al.Correlation of plasma copeptin and vasopress in concentrations in hypoiso- and hyperosmolar states[J]. Journal of Clinical Endocrinology & Metabolism,2011,96:1046-1052.
[8] CHRIST-CRAIN M, FENSKE W.Copeptin in the diagnosis of vasopressin-dependent disorders of fluid homeostasis[J]. Nature Reviews Endocrinology, 2016,12:168-176.
[9] BOECKEL J N, OPPERMANN J, ANADOL R, et al.Analyzing the release of copeptin from the heart in acute myocardial infarction using a transcoronary gradient model[J]. Scientific Reports, 2016, 6:208-212.
[10] BHANDARI S S, LOKE I, DAVIES J E, et al.Gender and renal function influence plasma levels of copeptin in healthy individuals[J]. Clinical Science,2009,116:257-263.
[11] BARAT C, SIMPSON L, BRESLOW E.Properties of human vasopressin precursor constructs: inefficient monomer folding in the absence of copeptin as a potential contributor to diabetes insipidus[J]. Biochemistry,2004,45(25):8191-8203.
[12] MUELLER C.Biomarkers and acute coronary syndromes: an update[J]. European Heart Journal,2014,35(9):552-556.
[13] REINSTADLER S J, KLUG G, FEISTRITZER H J, et al.Long-term predictive value of copeptin after acutemyocardial infarction: a cardiacmagnetic resonance study[J]. International Journal of Cardiology, 2014,172(2):359-360.
[14] REINSTADLER S J, KLUG G, FEISTRITZER H J, et al.Association of copeptin with myocardial infarct size and myocardial function after ST segment elevation myocardial infarction[J]. Heart, 2013,99(20):1525-1529.
[15] LIPINSKI M J, ESCARCEGA R O, ASCENZO F D, et al.A systematic review and collaborative meta-analysis to determine the incremental value of copeptin for rapid rule-out of acute myocardial infarction[J]. The American Journal of Cardiology, 2014,113(9):1581-1591.
[16] ROFFI M, PATRONO C, COLLET J P, et al.2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task force for the management of acute coronary syndromes in patients presenting without persistent ST-Segment Elevation of the EuropeanSociety of Cardiology[J]. European Heart Journal, 2016,37:267-315.
[17] REICHLIN T, HOCHHOLZER W, STELZIG C, et al.Incremental value of copeptin for rapid rule out of acute myocardial infarction[J]. Journal of the American College of Cardiology, 2009,54:60-68.
[18] KELLER T, TZIKAS S, ZELLER T, et al.Copeptin improves early diagnosis of acute myocardial infarction[J]. Journal of the American College of Cardiology, 2010,55:2096-2106.
[19] CRISTIAN P, MARC A.Copeptin as a diagnostic biomarker for sepsis-related deaths[J]. Peptides, 2014, 59:75-78.
[20] 郭文玉, 王小庆, 邹春霞, 等.尾加压素Ⅱ浓度与冠状动脉粥样硬化程度的关系探讨[J].中西医结合心脑血管病杂志,2016,14(8):879-881.
[21] KATAN M, FLURI F, MORGENTHALER N G, et al.Copeptin: a novel, independent prognosticmarker in patientswith ischemic stroke[J]. Annals of Neurology, 2009, 66(6): 799-808.
[22] ENHORNING S, BANKIR L, BOUBY N, et al.Copeptin a marker of vasopressin in abdominal obesity diabetes and microalbuminuria: the prospective Malmo Diet and Cancer Study cardiovascular cohort[J]. International Journal of Obesity, 2013,37(4):598-603.
[23] MULLER B, MORGENTHALER N, STOLZ D, et al.Circulating levels of copeptin, a novel biomarker in lower respiratory tract infections[J]. European Journal of Clinical Investigation, 2007, 37(2):145-152.
[24] SANG G, DU J M, CHEN J J, et al.Plasma copeptin levels are associated with prognosis of severe acute pancreatitis[J]. Peptides, 2014, 51:4-8.
[25] 朱泽磊, 王鹏, 尤家斌, 等. IMA和H-FABP在心源性猝死法医学诊断中的应用[J]. 法医学杂志,2017,33(4):393-396.
[26] CHAN D, NG L L.Biomarkers in acute myocardial infarction[J]. BMC Medicine, 2010(8): 34.

115

Accesses

0

Citation

Detail
Sections
Recommended
京ICP备09053967号-3
Copyright © Forensic Science and Technology, All Rights Reserved.
Tel: 010-66269489，010-83752624　E-mail: xsjsbjb@163.com
Powered by Beijing Magtech Co., Ltd.

/

〈 〉